Literature DB >> 23827827

[Nosocomial pneumonia].

Emili Díaz1, Ignacio Martín-Loeches, Jordi Vallés.   

Abstract

The hospital acquired pneumonia (HAP) is one of the most common infections acquired among hospitalised patients. Within the HAP, the ventilator-associated pneumonia (VAP) is the most common nosocomial infection complication among patients with acute respiratory failure. The VAP and HAP are associated with increased mortality and increased hospital costs. The rise in HAP due to antibiotic-resistant bacteria also causes an increase in the incidence of inappropriate empirical antibiotic therapy, with an associated increased risk of hospital mortality. It is very important to know the most common organisms responsible for these infections in each hospital and each Intensive Care Unit, as well as their antimicrobial susceptibility patterns, in order to reduce the incidence of inappropriate antibiotic therapy and improve the prognosis of patients. Additionally, clinical strategies aimed at the prevention of HAP and VAP should be employed in hospital settings caring for patients at risk for these infections.
Copyright © 2013 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Hospital-acquired pneumonia; Infección nosocomial; Neumonía asociada a ventilación mecánica; Neumonía nosocomial; Nosocomial infection; Ventilator-associated pneumonia

Mesh:

Year:  2013        PMID: 23827827     DOI: 10.1016/j.eimc.2013.04.014

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  5 in total

1.  Case fatality rate related to nosocomial and ventilator-associated pneumonia in an ICU: a single-centre retrospective cohort study.

Authors:  Murat Yalçınsoy; Cuneyt Salturk; Hurıye Berk Takır; Semra Batı Kutlu; Ayşegul Oguz; Emine Aksoy; Merih Balcı; Feyza Kargın; Ozlem Yazıcıoglu Mocin; Nalan Adıguzel; Gokay Gungor; Zuhal Karakurt
Journal:  Wien Klin Wochenschr       Date:  2015-11-05       Impact factor: 1.704

2.  Treating nosocomial pneumonia: what's new.

Authors:  Frantzeska Frantzeskaki; Stylianos E Orfanos
Journal:  ERJ Open Res       Date:  2018-06-26

3.  Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Authors:  Antoni Torres; Michael S Niederman; Jean Chastre; Santiago Ewig; Patricia Fernandez-Vandellos; Hakan Hanberger; Marin Kollef; Gianluigi Li Bassi; Carlos M Luna; Ignacio Martin-Loeches; J Artur Paiva; Robert C Read; David Rigau; Jean François Timsit; Tobias Welte; Richard Wunderink
Journal:  ERJ Open Res       Date:  2018-06-26

4.  Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection.

Authors:  Jose R Vargas-Rodriguez; Idalia Garza-Veloz; Virginia Flores-Morales; Jose I Badillo-Almaraz; Maria R Rocha-Pizaña; José J Valdés-Aguayo; Margarita L Martinez-Fierro
Journal:  Front Med (Lausanne)       Date:  2022-01-13

5.  [Recommendations for the care of patients with community-acquired pneumonia in the Emergency Department].

Authors:  A Julián-Jiménez; I Adán Valero; A Beteta López; L M Cano Martín; O Fernández Rodríguez; R Rubio Díaz; M A Sepúlveda Berrocal; J González Del Castillo; F J Candel González
Journal:  Rev Esp Quimioter       Date:  2018-04-05       Impact factor: 1.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.